Client News

Andera Partners strengthens its position among the leading players in private equity

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

Newron Secures Up to EUR 38 Million to Advance Phase III Evenamide Program

PL BioScience Wins Regulatory Certification from Japan’s PMDA

Rentschler Biopharma appoints Dr. Veit Bergendahl as Chief Operating Officer and member of the executive board

Lotus Pharmaceutical becomes commercialization partner for Formycon’s Keytruda® biosimilar candidate FYB206 across major parts of the Asia-Pacific Region

CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System

Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia

InflaRx Announces Participation in February Investor Conferences

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.